GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC

Rank in Stocks #34366
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Share Price
$0.00001
Last synced: 2026-11-17
Market Cap
$12.09K
Change (1 day)
-90.00%
Change (1 year)
-90.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade GlobeStar Therapeutics Corporation (GSTC)

Category

Healthcare
Operating Margin for GlobeStar Therapeutics Corporation (GSTC)
Operating Margin as of November 2026 TTM: 0.00%
According to GlobeStar Therapeutics Corporation's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2023 the company had an operating margin of 0.00%.
Operating Margin history for GlobeStar Therapeutics Corporation from 2010 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% -100.00%
2020 -394,805.19% 430.99%
2019 -74,352.94% 88.53%
2018 -39,438.20% 0.00%
2017 0.00% 0.00%
2016 0.00% -100.00%
2015 -1,655.87% 251.61%
2014 -470.94% -58.13%
2013 -1,124.80% -434.46%
2012 336.30% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
29.35% -
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about GlobeStar Therapeutics Corporation's operating margin

What was GlobeStar Therapeutics Corporation's operating margin in 2023?

In 2023, GlobeStar Therapeutics Corporation's operating margin was 0.00%, compared with 0.00% in 2022.

How has GlobeStar Therapeutics Corporation's operating margin changed since 2018?

From 2018 to 2023, GlobeStar Therapeutics Corporation's operating margin was highest in 2023 (0.00%) and lowest in 2020 (-394,805.19%).

How does GlobeStar Therapeutics Corporation's operating margin compare with similar companies?

GlobeStar Therapeutics Corporation's operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.